Uddin, Md Jasim, Economidou, Sophia Nikoletta, Guiraud, Léa, Kazi, Mohsin, Alanazi, Fars K. and Douroumis, Dennis ORCID: 0000-0002-3782-0091 (2024) Monoclonal antibody delivery using 3D printed biobased hollow μNe3dle arrays for the treatment of osteoporosis. Molecular Pharmaceutics, 21. pp. 4465-4475. ISSN 1543-8384 (Print), 1543-8392 (Online) (doi:https://doi.org/10.1021/acs.molpharmaceut.4c00379)

Preview

PDF (Open Access article) 48547 DOUROUMIS_Monoclonal_Antibody_Delivery_Using_3D_Printed_Biobased_Hollow_μNe3dle_Arrays_(OA)_2024.pdf - Published Version Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (8MB) | Preview

Abstract

Transdermal microneedles have demonstrated promising potential as an alternative to typical drug administration routes for the treatment of various diseases. As microneedles offer lower administration burden with enhanced patient adherence and reduced ecological footprint, there is a need for further exploitation of microneedle devices. One of the main objectives of this work was to initially develop an innovative biobased photocurable resin with high biobased carbon content comprising isobornyl acrylate (IBA) and pentaerythritol tetraacrylate blends (50:50 wt/wt). The optimization of the printing and curing process resulted in μNe3dle arrays with durable mechanical properties and piercing capacity. Another objective of the work was to employ the 3D printed hollow μNe3dles for the treatment of osteoporosis in vivo. The 3D printed μNe3dle arrays were used to administer denosumab (Dmab), a monoclonal antibody, to osteoporotic mice, and the serum concentrations of critical bone minerals were monitored for six months to assess recovery. It was found that the Dmab administered by the 3D printed μNe3dles showed fast in vitro rates and induced an enhanced therapeutic effect in restoring bone-related minerals compared to subcutaneous injections. The findings of this study introduce a novel green approach with a low ecological footprint for 3D printing of biobased μNe3dles, which can be tailored to improve clinical outcomes and patient compliance for chronic diseases.

Item Type:	Article
Additional Information:	Published as part of the Molecular Pharmaceutics virtual special issue “Recent Developments in Transdermal Microneedle Drug Delivery.”
Uncontrolled Keywords:	3D printing, digital, light processing, microneedles, monoclonal antibody, osteoporosis
Subjects:	Q Science > Q Science (General) R Medicine > R Medicine (General) T Technology > T Technology (General)
Faculty / School / Research Centre / Research Group:	Faculty of Engineering & Science Faculty of Engineering & Science > School of Science (SCI)
Last Modified:	06 Nov 2024 09:58
URI:	http://gala.gre.ac.uk/id/eprint/48547

Actions (login required)

View Item

Downloads